End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.854 EUR | -4.26% | -13.03% | -70.55% |
05-15 | Acticor: 'new perspectives' in stroke treatment | CF |
05-15 | Acticor Biotech Announces Presentation of the Main Results of the Phase 2/3 Actisave Study in the Treatment of Stroke at ESOC 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-70.55% | 12.14M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-2.33% | 21.58B | |
-6.03% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- ALACT Stock
- News Acticor Biotech SAS
- Acticor Biotech SAS has completed an IPO in the amount of €15.508613 million.